PARTNERSHIPS

Laboratoires THERABEL LUCIEN PHARMA benefit from numerous strategic alliances in order to develop their pharmaceutical activities in France through commercial partnerships. Numerous licence and joint marketing agreements have also been signed with certain international pharmaceutical groups such as HELSINN and ZAMBON. 

Licence agreements
- HELSINN HEALTHCARE (Switzerland): Nexen®,
- ZAMBON (Italy): Joint marketing of Uridoz®.

DEVELOPMENT OBJECTIVES

Laboratoires THERABEL LUCIEN PHARMA will continue to pursue this partnership strategy in the future, in order to:

- acquire new products under licence, and market them in France,
- take part in Research and Development projects, together with phase-III joint clinical development programmes.

Contact the Business Development Director